Herpes simplex virus 1 & 2 (HSV1 & 2) nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device ID
- 132457
- MHRA Reference Number
- 132457
- Date Registered
- Nov 26, 2024
- Last Updated
- Jul 6, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Herpes simplex virus 1 & 2 (HSV1 & 2) nucleic acid IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Address
- 12212 Technology Blvd Austin, Texas, United States
- Created Date
- Dec 23, 2021
- Relationship Type
- UK Responsible Person
- Address
- Central Road Dartford, England, United KingdomPostcode: DA1 5LR
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by DiaSorin Italia S.p.A. UK Branch in the UK
Herpes simplex virus 1 & 2 (HSV1 & 2) nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 132457. The device is manufactured by Luminex Corporation from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is DiaSorin Italia S.p.A. UK Branch.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.